In a groundbreaking revelation, Future Market Insights (FMI), a globally recognized market intelligence and consulting firm, has shed light on a promising future for the Global Amino Acid Metabolism Disorders Treatment Industry. FMI’s comprehensive analysis has unveiled a robust compound annual growth rate (CAGR) of 6.4% forecasted from 2017 to 2026, propelling the industry toward an extraordinary milestone – a projected valuation exceeding US$1,030 million by the end of the forecast period.
FMI’s in-depth examination underscores the resilience and potential inherent in the Amino Acid Metabolism Disorders Treatment sector. This groundbreaking revelation emphasizes the industry’s substantial growth trajectory, solidifying its pivotal role in shaping the global healthcare landscape over the next decade.
Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-6359
Key Insights on Global Amino Acid Metabolism Disorders Treatment Industry
Based on region, the Global Amino Acid Metabolism Disorders Treatment Industry has been segmented into North America, Europe, Latin America, Asia Pacific except Japan, Japan, and the Middle East and Africa. Amongst these, North America is expected to retain a leading position in the market by the end of the forecast period reaching a valuation of over US$359 Mn. North America is expected to be closely followed by Europe. Players operating in this market can seek potential opportunities from the U.S., Germany, Spain, and France owing to several clinical trials taking place about this treatment and several mergers and acquisitions occurring among core players operating in these regions. Players can also find lucrative opportunities from Asia Pacific excluding Japan and as well with the rise in nutritional management activities in these regions. Countries in APAC such as China and India are also expected to emerge as potential adopters of amino acid metabolism disorders treatment in the long run.
In terms of product type, the global amino acid metabolism disorder treatment market has been segmented into arginine, folic acid, vitamin B6 and B12, thiamine, vitamin D, betaine, carglumic acid, sapropterin dihydrocholoride, and others. Among these, carglumic acid is expected to lead the market until the end of the forecast period reaching a valuation of over US$185 Mn. However, sapropterin dihydrocholoride is expected to witness the maximum growth rate throughout the forecast period.
Based on indication, the global market for amino acid metabolism disorder treatment has been classified into phenylketonuria, maple syrup urine disease, argininosuccinic acidemia, citrullinemia, and homocystinuria. Among all of these, phenylketonuria is expected to emerge dominant by the end of the forecast period.
Based on sales channel, the global market for amino acid metabolism disorder treatment has been classified into hospital pharmacies, retail pharmacies, and online sales. Hospital pharmacies is expected to take the lead among all these by the end of the forecast period.
Click Here to Request Methodology!
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-6359
Vendor Landscape
The companies operating in the market are Pfizer, Inc., GlaxoSmithKline PLC, Merck KGaA, Koninklijke DSM N.V., Recordati S.p.A., Sanofi, Civentichem, LLC, Shine Star (Hubei) Biological Engineering Co., Ltd., AMINO GmbH, and Kyowa Hakko Kirin Co., Ltd.
Global Amino Acid Metabolism Disorders Treatment Industry: Taxonomy
Region:
- North America
- Latin America
- Europe
- Japan
- APEJ
- MEA
Product Type:
- Arginine
- Folic Acid
- Vitamin B6 & B12
- Thiamine
- Vitamin D
- Betaine
- Carglumic Acid
- Sapropterin Dihydrochloride
- Others
Indication:
- Phenylketonuria
- Maple Syrup Urine Disease
- Argininosuccinic Acidemia
- Citrullinemia
- Homocystinuria
Sales Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Sales
Click Here To Buy Your Detailed Report
https://www.futuremarketinsights.com/checkout/6359
Author
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube